CLINICAL_TRIALS
trial_result
· 2016-08-01
Clinical Trial Update: A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma [Phase 2]
Summary
A Phase 2 trial evaluating QBX258 in patients with moderate to severe asthma has completed and posted efficacy results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2016-08-01